|
REPORT
Of a Clinical Trial of
Siberian Cedar Nut Oil
Bearing the Ringing Cedars of Russia Trademark
Part I
The clinical trial was conducted in a random population group in outpatient conditions. In total, 22 persons from 20 to 52 years of age (the average age was 37.2 +/- 2.4 years) were included in the trial. The persons studied belonged to the category of students (5 persons) and employed persons (17 persons). All of the persons observed had a pathology of the digestive organs. Gastroesophageal reflux disease was observed in 8 persons; erosive gastroduodenitis, in 9 persons; peptic ulcer of the stomach and duodenum, in 4 persons; and postoperative stomach disease, in 1 person.
For the evaluation of the criteria of the effectiveness of Cedar Nut Oil of Ringing Cedars of Russia Trademark, a standard questionnaire for the evaluation of the quality of life was used -the Nottingham Health Profile. All patients were surveyed prior to beginning taking the preparations and after 20 days.
Results
The results of the trials are presented in the table.
After the detection of the disease, in persons 20 years of age in the group under study (5 persons), the lowering of the quality of life indicators was minimal. Following the course of treatment with Siberian cedar oil bearing the Ringing Cedars of Russia trademark, a reliable improvement was noted (P<0.05-0.02), as was the full restoration of the evaluated quality of life parameters.
In persons in the older age groups (17 persons), the lowering of the quality of life indicators was more significant. However, on the completion of the course of treatment with Siberian cedar oil bearing the Ringing Cedars of Russia trademark, a significant and reliable improvement (P<0.001-0.05) was noted in the quality of life indicators.
As a whole, in the entire group of persons studied, the most noticeable improvement was observed in the improvement of emotional reactions and the restoration of sleep.
Table. Results of the surveyed patients from 20 to 52 years of age
Time
observed |
Energy
level |
Pain |
Emotional
reactions |
Sleep |
Social
isolation |
Physical
abilities |
Before treatment
(n = 22) |
30.6 +/- 7.6 |
9.1 +/- 2.6 |
12.0+/- 3.1 |
18.1 +/- 4.8 |
7.9 +/- 3.0 |
7.4 +/- 1.8 |
After treatment
(n = 22) |
15.6 +/- 6.6* |
3.7 +/- 1.3* |
2.5 +/- 1.5* |
5.7 +/- 2.2* |
1.6 +/- 1.1* |
3.9 +/- 1.4 |
Note: An asterisk indicates differences that are statistically reliable in comparison to the initial level (P<0.05)
Clinical tests conducted by:
A. B. Krivosheev
Professor of the Department of Internal Medicine
Doctor of Medical Sciences
http://www.RingingCedarsofRussia.org/
Used by Permission
Copyright http://www.cedarinfo.info/
These articles come directly from researchers and are passed on to everybody. The company assumes no liability for any content in these articles.
For Educational purposes only.
This information has not been evaluated by the Food and Drug Administration.
This information is not intended to diagnose, treat, cure, or prevent any disease
http://www.ringingcedarsofrussia.org/
Used by permission.
© Copyright CedarInfo.Info
RingingCedarsofRussia.org assumes no liability for any content in these articles.
| 
